| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| HLA-A*1101 & B2M & KRASG12A (VVVGAAGVGK) | Biotinylated Human HLA-A*11:01&B2M&KRASG12A (VVVGAAGVGK) Complex Protein (Monomer, MALS verified) |  Human | HEK293 | MALSSDS-PAGE | $125.00 25ug |   |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| CB-2202 | CB-2202 | Phase 2 Clinical | Cennerv Pharma | Depressive Disorder, Major | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Toloxatone | MD-69276 | Approved | Umoril, Humoryl, Perenum | France | Depression | null | 1984-01-01 | Depression | Details |
